Mresvia Dosage
Generic name: RNA-100-AR02 50ug in 0.5mL
Dosage form: injection
Drug class: Viral vaccines
Medically reviewed by Drugs.com. Last updated on Jun 12, 2025.
Preparation for Administration
MRESVIA is supplied as a pre-filled syringe that contains a frozen suspension that must be thawed prior to administration.
Thaw each syringe before use, either in the refrigerator or at room temperature, following the instructions in Table 1.
| Configuration | Thaw in Refrigerator | Thaw at Room Temperature |
|---|---|---|
|
Carton of 1 pre-filled syringe |
Thaw between 2°C to 8°C (36°F to 46°F) for 100 minutes. |
Thaw between 15°C to 25°C (59°F to 77°F) for 40 minutes. |
|
Carton of 2 pre‑filled syringes |
Thaw between 2°C to 8°C (36°F to 46°F) for 100 minutes. |
Thaw between 15°C to 25°C (59°F to 77°F) for 40 minutes. |
|
Carton of 10 pre-filled syringes |
Thaw between 2°C to 8°C (36°F to 46°F) for 160 minutes. |
Thaw between 15°C to 25°C (59°F to 77°F) for 80 minutes. |
|
One syringe (removed from carton) |
Thaw between 2°C to 8°C (36°F to 46°F) for 100 minutes. |
Thaw between 15°C to 25°C (59°F to 77°F) for 40 minutes. |
- •
- After thawing, do not refreeze.
- •
- Syringes should not be returned to the refrigerator after standing at room temperature.
- •
- Pre-filled syringes may be stored at 8°C to 25°C (46°F to 77°F) for a total of 24 hours after removal from refrigerated conditions. Discard the thawed pre-filled syringe if not used within this time.
- •
- Do not shake.
- •
- Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
- •
- MRESVIA is a white to off-white suspension that may contain visible white or translucent product-related particulates. Do not administer if the vaccine is discolored or contains other particulate matter.
More about mRESVIA (rsv vaccine, mrna)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: viral vaccines
Patient resources
Professional resources
Related treatment guides
See also:
Arexvy
Arexvy is a vaccine used to prevent respiratory syncytial virus (RSV) lower respiratory tract ...
Abrysvo
Abrysvo is a vaccine used to prevent respiratory syncytial virus (RSV) lower respiratory tract ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Beyfortus
Beyfortus is used to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in ...
Synagis
Synagis is used to prevent lung disease caused by respiratory syncytial virus. Learn about side ...
Enflonsia
Enflonsia is an FDA-approved medication used to prevent respiratory syncytial virus (RSV) lower ...
Nirsevimab
Nirsevimab information from Drugs.com, includes Nirsevimab side effects, interactions and indications.
Rsv vaccine, pref a-pref b, recombinant
Respiratory Syncytial Virus (RSV) vaccines (Abrysvo, Arexvy, mResvia) are used to help reduce the ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
